版本:
中国

BRIEF-Contravir Pharmaceuticals enters into amended, restated executive agreement with James Sapirstein, CFO

May 26 Contravir Pharmaceuticals Inc

* On May 25 entered into amended,restated executive agreement with James Sapirstein, chief executive officer - SEC filing

* Pursuant to agreement, Sapirstein's current base compensation is $480,000 per year Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐